ATA151279A - Verfahren zur herstellung von neuen mehrfach halogenierten steroiden - Google Patents

Verfahren zur herstellung von neuen mehrfach halogenierten steroiden

Info

Publication number
ATA151279A
ATA151279A AT151279A AT151279A ATA151279A AT A151279 A ATA151279 A AT A151279A AT 151279 A AT151279 A AT 151279A AT 151279 A AT151279 A AT 151279A AT A151279 A ATA151279 A AT A151279A
Authority
AT
Austria
Prior art keywords
halogened
steroids
producing new
new multiple
producing
Prior art date
Application number
AT151279A
Other languages
English (en)
Other versions
AT363202B (de
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to AT0151279A priority Critical patent/AT363202B/de
Publication of ATA151279A publication Critical patent/ATA151279A/de
Application granted granted Critical
Publication of AT363202B publication Critical patent/AT363202B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0151279A 1976-09-29 1979-02-28 Verfahren zur herstellung von neuen mehrfach halogenierten steroiden AT363202B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0151279A AT363202B (de) 1976-09-29 1979-02-28 Verfahren zur herstellung von neuen mehrfach halogenierten steroiden

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
LU75903A LU75903A1 (de) 1976-09-29 1976-09-29
AT0691077A AT363197B (de) 1976-09-29 1977-09-28 Verfahren zur herstellung von neuen 9alpha,21-dihalogen-11beta, 17alpha-dihydroxy-6alpha-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-verbindungen
AT0151279A AT363202B (de) 1976-09-29 1979-02-28 Verfahren zur herstellung von neuen mehrfach halogenierten steroiden

Publications (2)

Publication Number Publication Date
ATA151279A true ATA151279A (de) 1980-12-15
AT363202B AT363202B (de) 1981-07-27

Family

ID=19728370

Family Applications (3)

Application Number Title Priority Date Filing Date
AT0691077A AT363197B (de) 1976-09-29 1977-09-28 Verfahren zur herstellung von neuen 9alpha,21-dihalogen-11beta, 17alpha-dihydroxy-6alpha-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-verbindungen
AT0151279A AT363202B (de) 1976-09-29 1979-02-28 Verfahren zur herstellung von neuen mehrfach halogenierten steroiden
AT0151379A AT363203B (de) 1976-09-29 1979-02-28 Verfahren zur herstellung von neuen 9alpha,21-

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0691077A AT363197B (de) 1976-09-29 1977-09-28 Verfahren zur herstellung von neuen 9alpha,21-dihalogen-11beta, 17alpha-dihydroxy-6alpha-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-verbindungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT0151379A AT363203B (de) 1976-09-29 1979-02-28 Verfahren zur herstellung von neuen 9alpha,21-

Country Status (24)

Country Link
JP (1) JPS5356652A (de)
AT (3) AT363197B (de)
AU (1) AU514200B2 (de)
BE (1) BE859120A (de)
CA (1) CA1101410A (de)
CH (9) CH624967A5 (de)
CY (1) CY1178A (de)
DD (1) DD133150A5 (de)
DE (1) DE2743069C2 (de)
DK (1) DK146017C (de)
ES (1) ES462763A1 (de)
FR (1) FR2366311A1 (de)
GB (1) GB1563638A (de)
HK (1) HK16683A (de)
HU (1) HU175218B (de)
IE (1) IE46047B1 (de)
IL (1) IL53012A (de)
KE (1) KE3258A (de)
LU (1) LU75903A1 (de)
MY (1) MY8400092A (de)
NL (1) NL7710089A (de)
SE (1) SE436751B (de)
SG (1) SG3383G (de)
ZA (1) ZA775800B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
EP0523132A1 (de) * 1990-03-27 1993-01-20 Schering Corporation Verfahren zur dehydrierung von 9-alpha-hydroxy-steroiden
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
BR0214520A (pt) 2001-11-29 2006-05-30 Taro Pharmaceuticals Usa Inc método para a preparação de corticosteróides de 6alfa-fluoro
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
KR102643849B1 (ko) 2015-06-18 2024-03-07 밸리언트 파마슈티컬즈 노오쓰 아메리카 엘엘씨 건선을 치료하기 위한 코르티코스테로이드 및 레티노이드를 포함하는 국소 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
HU175218B (hu) 1980-06-28
CH631998A5 (en) 1982-09-15
ES462763A1 (es) 1978-05-16
CH632000A5 (en) 1982-09-15
JPS5356652A (en) 1978-05-23
SE7706673L (sv) 1978-03-30
CA1101410A (en) 1981-05-19
CH632521A5 (en) 1982-10-15
CH625808A5 (en) 1981-10-15
DK146017B (da) 1983-05-24
JPS6214557B2 (de) 1987-04-02
FR2366311B1 (de) 1982-12-03
ZA775800B (en) 1978-08-30
AU514200B2 (en) 1981-01-29
CH625809A5 (en) 1981-10-15
AT363202B (de) 1981-07-27
CH625810A5 (en) 1981-10-15
KE3258A (en) 1983-03-04
CH631999A5 (en) 1982-09-15
NL7710089A (nl) 1978-03-31
AU2914877A (en) 1979-04-05
BE859120A (fr) 1978-03-28
DK146017C (da) 1983-10-24
DD133150A5 (de) 1978-12-13
DK256977A (da) 1978-03-30
CY1178A (en) 1983-06-10
SG3383G (en) 1983-09-09
LU75903A1 (de) 1978-05-16
SE436751B (sv) 1985-01-21
ATA151379A (de) 1980-12-15
IE46047B1 (en) 1983-02-09
HK16683A (en) 1983-05-27
DE2743069A1 (de) 1978-03-30
CH632279A5 (en) 1982-09-30
CH624967A5 (en) 1981-08-31
FR2366311A1 (fr) 1978-04-28
GB1563638A (en) 1980-03-26
ATA691077A (de) 1980-12-15
IL53012A (en) 1982-05-31
IE46047L (en) 1978-03-29
DE2743069C2 (de) 1987-03-05
AT363203B (de) 1981-07-27
IL53012A0 (en) 1977-11-30
MY8400092A (en) 1984-12-31
AT363197B (de) 1981-07-10

Similar Documents

Publication Publication Date Title
AT356827B (de) Verfahren zur herstellung von neuen spirol- actonen
AT358727B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT356136B (de) Verfahren zur herstellung von neuen spiro- hydantoinen
AT359187B (de) Verfahren zur herstellung von neuen 7-beta-(2- -oxyimino-2-arylacetamido)-cephalosporinen
AT363478B (de) Verfahren zur herstellung von neuen oxepanderivaten
AT370110B (de) Verfahren zur herstellung von neuen 4-androsten-3-onen
AT358200B (de) Verfahren zur herstellung von neuen steroid- -enolestern
ATA151279A (de) Verfahren zur herstellung von neuen mehrfach halogenierten steroiden
AT360185B (de) Verfahren zur herstellung von neuen dehydro- digopeptiden
AT361638B (de) Verfahren zur herstellung von neuen dimeren indoldihydroindoldionen
AT362786B (de) Verfahren zur herstellung von neuen 1-acyl-2-imidazolinen
AT358726B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT360037B (de) Verfahren zur herstellung von neuen substi- tuierten phenylguanidinen
AT351191B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT355743B (de) Verfahren zur herstellung von neuen kortikoiden
AT364364B (de) Verfahren zur herstellung von neuen thiepinen
AT375931B (de) Verfahren zur herstellung von neuen aminoalkylfuranderivaten
AT360646B (de) Verfahren zur herstellung von neuen cephalos- porinen
AT343623B (de) Verfahren zur herstellung von neuen n-alkyl -4-nitro-2- trifluormethyldiphenylaminen
ATA175879A (de) Verfahren zur herstellung von neuen antitumorglycosiden
ATA656076A (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT355210B (de) Verfahren zur herstellung von neuen 1-oxa- dethiacephalosporinen
AT355039B (de) Verfahren zur herstellung von neuen veraetherten hydroxy-benzimidazolonen, - benzoxazolonen, -benzoxazinonen,- china- zolinonen und -chinoxazolinonen
AT364367B (de) Verfahren zur herstellung von neuen oxepinen
ATA57779A (de) Verfahren zur herstellung von neuen 1-oxa- dethiacephalosporinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
ELA Expired due to lapse of time